Ledger.Open graph →
SEC Form D · Amendment · filed May 17, 2024

Hopewell Therapeutics, Inc

Offering
$10.0M
Sold
$7.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Woburn, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Xutian V. Jing · Woburn, MADirectorQiaobing V. Xu · Woburn, MAExec · DirectorJake Xia · Woburn, MADirectorThomas Hennessey · Woburn, MADirectorNan V. Shen · Woburn, MADirectorBrian L. Burns · PHOENIX, AZDirectorJames L. Goulka · PHOENIX, AZDirectorKjiel Carlson · El Segundo, CAExec · DirectorLiat Bycel · San Francisco, CADirectorNan V. Shen · Woburn, MADirectorJesse Clurman · BROOKLYN, NYDirectorC. E. Springman · Bellevue, WAExec · DirectorSara Loewel · BROOKLYN, NYDirectorDavid Karandish · St. Louis, MODirectorJonathan Reis · Wellesley, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗